CytoDyn Inc. Files 8-K with Corporate Updates

TL;DR

CYDY filed an 8-K on Nov 21, 2025, covering bylaws, shareholder votes, and financials. Stay tuned.

AI Summary

CytoDyn Inc. filed an 8-K on November 21, 2025, reporting on several key corporate events. These include amendments to its articles of incorporation or bylaws, the submission of matters to a vote of security holders, and the filing of financial statements and exhibits. The company, incorporated in Delaware, is in the pharmaceutical preparations industry.

Why It Matters

This filing provides shareholders and potential investors with crucial updates on the company's governance, financial reporting, and strategic decisions, impacting their investment outlook.

Risk Assessment

Risk Level: medium — 8-K filings can signal significant corporate changes, but the specific details of this filing (bylaws, votes, financials) require further analysis to determine the precise risk level.

Key Players & Entities

• CytoDyn Inc. (company) — Registrant
• November 21, 2025 (date) — Date of Report
• Delaware (jurisdiction) — State of Incorporation
• 1111 Main Street, Suite 660 (address) — Principal Executive Offices
• Vancouver, Washington (location) — Principal Executive Offices Location
• 360-980-8524 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.001 — rized shares of common stock, par value $0.001 per share, from 1,750,000,000 to 2,250,

Filing Documents

• cydy-20251121x8k.htm (8-K) — 69KB
• cydy-20251121xex3d1.htm (EX-3.1) — 12KB
• 0001104659-25-115056.txt ( ) — 188KB
• cydy-20251121.xsd (EX-101.SCH) — 3KB
• cydy-20251121_lab.xml (EX-101.LAB) — 14KB
• cydy-20251121_pre.xml (EX-101.PRE) — 9KB
• cydy-20251121x8k_htm.xml (XML) — 4KB

03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On November 21, 2025, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the "Certificate of Amendment") to its Certificate of Incorporation, increasing the total number of authorized shares of common stock, par value $0.001 per share, from 1,750,000,000 to 2,250,000,000. A copy of the Certificate of Amendment is attached hereto as Exhibit 3.1 and incorporated by reference herein.

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. CytoDyn Inc. (the "Company") held its 2025 Annual Meeting of Stockholders (the "Annual Meeting") on November 21, 2025. On November 21, 2025, the Inspector of Election issued its final report certifying the final voting results for the Annual Meeting, which were as follows: 1. Election of Directors. Nominee For Withheld Broker Non-Votes Tanya Durkee Urbach 422,993,702 86,884,590 234,761,991 Stephen M. Simes 461,503,424 48,374,868 234,761,991 Ryan M. Dunlap 465,428,046 44,450,246 234,761,991 Lishomwa C. Ndhlovu, M.D., Ph.D. 462,857,219 47,021,073 234,761,991 Karen J. Brunke, Ph.D. 463,364,278 46,514,014 234,761,991 The stockholders elected each of the Company's director nominees to serve until the Company's 2026 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation, or removal. 2. Advisory vote on selection of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending May 31, 2026. For Against Abstentions 721,348,317 17,565,874 5,726,090 The stockholders approved, on an advisory basis, the selection of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending May 31, 2026. 3. Advisory vote on compensation of named executive officers. For Against Abstentions Broker Non-Votes 389,864,422 108,351,482 11,662,388 234,761,991 The stockholders approved, on an advisory basis, the compensation paid to the Company's named executive officers. 4. Advisory vote on the frequency of holding an advisory vote on executive compensation. One Year Two Years Three Years Abstentions Broker Non-Votes 451,446,382 17,451,685 11,563,946 29,416,278 234,761,992 The stockholders voted, on an advisory basis, to hold an advisory vote on executive compensation every one year. 5. Vote to amend the Company's certificate of inc

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) The following exhibit is filed with this Current Report on Form 8-K: Exhibit No. Description 3.1 Certificate of Amendment to the Certificate of Incorporation of CytoDyn Inc. dated November 21, 2025 104 Cover Page Interactive Data File (formatted as inline XBRL) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CYTODYN INC. Date: November 21, 2025 By /s/ Tyler Blok Tyler Blok Chief Legal Officer and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR